<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6395710</article-id><article-id pub-id-type="pmid">30816229</article-id><article-id pub-id-type="publisher-id">39583</article-id><article-id pub-id-type="doi">10.1038/s41598-019-39583-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Viscosin-like lipopeptides from frog skin bacteria inhibit <italic>Aspergillus fumigatus</italic> and <italic>Batrachochytrium dendrobatidis</italic> detected by imaging mass spectrometry and molecular networking</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martin H.</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6711-6719</contrib-id><name><surname>Nothias</surname><given-names>Louis-F&#x000e9;lix</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8093-596X</contrib-id><name><surname>Boya P.</surname><given-names>Cristopher A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Reinert</surname><given-names>Laura K.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Rollins-Smith</surname><given-names>Louise A.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3003-1030</contrib-id><name><surname>Dorrestein</surname><given-names>Pieter C.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1423-3772</contrib-id><name><surname>Guti&#x000e9;rrez</surname><given-names>Marcelino</given-names></name><address><email>mgutierrez@indicasat.org.pa</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1800 2151</institution-id><institution-id institution-id-type="GRID">grid.452535.0</institution-id><institution>Centro de Biodiversidad y Descubrimiento de Drogas, </institution><institution>Instituto de Investigaciones Cient&#x000ed;ficas y Servicios de Alta Tecnolog&#x000ed;a (INDICASAT AIP), </institution></institution-wrap>Panama, Republic of Panama </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9211 2181</institution-id><institution-id institution-id-type="GRID">grid.411114.0</institution-id><institution>Department of Biotechnology, </institution><institution>Acharya Nagarjuna University, </institution></institution-wrap>Guntur, India </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2296 9689</institution-id><institution-id institution-id-type="GRID">grid.438006.9</institution-id><institution>Smithsonian Tropical Research Institute, </institution></institution-wrap>Balboa, Ancon Republic of Panama </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0636 5254</institution-id><institution-id institution-id-type="GRID">grid.10984.34</institution-id><institution>Departamento de Zoolog&#x000ed;a, </institution><institution>Universidad de Panam&#x000e1;, </institution></institution-wrap>Panama, Republic of Panama </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, </institution><institution>University of California San Diego, La Jolla, </institution></institution-wrap>California, USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2264 7217</institution-id><institution-id institution-id-type="GRID">grid.152326.1</institution-id><institution>Department of Pathology, Microbiology, and Immunology, and Department of Pediatrics, </institution><institution>Vanderbilt University School of Medicine, </institution></institution-wrap>Nashville, Tennessee USA </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2264 7217</institution-id><institution-id institution-id-type="GRID">grid.152326.1</institution-id><institution>Department of Biological Sciences, </institution><institution>Vanderbilt University, </institution></institution-wrap>Nashville, Tennessee USA </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><elocation-id>3019</elocation-id><history><date date-type="received"><day>17</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Amphibian populations worldwide have declined and in some cases become extinct due to chytridiomycosis, a pandemic disease caused by the fungus <italic>Batrachochytrium dendrobatidis</italic>; however, some species have survived these fungal epidemics. Previous studies have suggested that the resistance of these species is due to the presence of cutaneous bacteria producing antifungal metabolites. As our understanding of these metabolites is still limited, we assessed the potential of such compounds against human-relevant fungi such as <italic>Aspergillus</italic>. In this work we isolated 201 bacterial strains from fifteen samples belonging to seven frog species collected in the highlands of Panama and tested them against <italic>Aspergillus fumigatus</italic>. Among the 29 bacterial isolates that exhibited antifungal activity, <italic>Pseudomonas cichorii</italic> showed the greatest inhibition. To visualize the distribution of compounds and identify them in the inhibition zone produced by <italic>P. cichorii</italic>, we employed MALDI imaging mass spectrometry (MALDI IMS) and MS/MS molecular networking. We identified viscosin and massetolides A, F, G and H in the inhibition zone. Furthermore, viscosin was isolated and evaluated <italic>in vitro</italic> against <italic>A. fumigatus</italic> and <italic>B. dendrobatidis</italic> showing MIC values of 62.50&#x02009;&#x000b5;g/mL and 31.25&#x02009;&#x000b5;g/mL, respectively. This is the first report of cyclic depsipeptides with antifungal activity isolated from frog cutaneous bacteria.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Chytridiomycosis is a lethal infectious disease that is affecting amphibians worldwide. It is caused by the pathogenic fungi <italic>Batrachochytrium dendrobatidis</italic><sup><xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref></sup> and <italic>B. salamandrivorans</italic><sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. <italic>Batrachochytrium dendrobatidis</italic> has caused the decline of a wide range of amphibians in several regions of the world including Australia, Southern Europe, North America and the Neotropical region. In contrast, <italic>B. salamandrivorans</italic> is thought to have originated in Asia, but has caused lethal outbreaks only in Europe and mainly affecting salamanders<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. On the other hand, aspergillosis is a fungal disease that affect humans and other vertebrates<sup><xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref></sup>, most frequently caused by the opportunistic fungus <italic>Aspergillus fumigatus</italic>. In humans, this disease is generally treated successfully with traditional antifungal drugs. However, the rise of drug-resistant cases of aspergillosis<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> is producing serious concerns in the medical community<sup><xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref></sup>, and the discovery of alternative antifungal drugs with different mechanisms of action is imperative.</p><p id="Par3">Despite the amphibian declines caused by <italic>B. dendrobatidis</italic> in Central America and Panama<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, some species are resistant to the fungal outbreaks and in some cases species may be recovering<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. This resistance has been mainly attributed to chemical defenses comprised of antifungal skin secretions and secondary metabolites produced by epibiotic microbes on the skin of amphibians<sup><xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref></sup>. Although many antagonistic interactions between microbes and <italic>B. dendrobatidis</italic> have been described<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>, only four metabolites produced by amphibian cutaneous bacteria have been reported. They include violacein, indol-3-carboxaldehyde, 2,4-diacthylphloroglucinol, and prodigiosin<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref></sup>. Therefore, the chemical diversity of the compounds involved of these host and microbe interactions is still untapped, providing an opportunity for bioinspired antifungal drug discovery<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. By exploring such novel natural sources of antifungals it is more likely to find different compounds with new mechanisms of action to enhance the therapeutic options for the control of fungal diseases<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. In fact, during the last 30 years, only three main classes of molecules have been used in clinical practice including, polyenes, azoles, and echinocandins<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. The latter are cyclic lipopeptides, which are molecules conformed by a fatty acid tail linked to a cyclic peptide. These molecules are of interest since they exhibit a broad spectrum of antimicrobial effects and have many biological roles in nature i.e., microbial antagonism, host-protection against predators, motility and biofilm formation<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>.</p><p id="Par4">Modern technologies like DNA sequencing and mass spectrometry-based analyses, such as Matrix Assisted Laser Desorption Ionization (MALDI) Imaging Mass Spectrometry (IMS) and MS/MS molecular networking, can be used together to study microbial interactions and chemical ecology. Using high throughput sequencing of 16S rRNA gene amplicons, researchers can assess the array of bacterial species that are present in biological samples. While MALDI IMS facilitates direct visualization of the distribution of metabolites produced by interacting microbes in a Petri dish and MS/MS molecular networking is used to identify a wide range of known and unknown molecules with medical relevance<sup><xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref></sup>. By combining these techniques 1) 16S rRNA gene sequencing, 2) MALDI IMS and 3) Tandem Mass Spectrometry (MS/MS) molecular networking, it is possible to study the nature and dynamics of the production of chemicals in single microbes and during microbial interactions. Herein, we used this multi-omics approach to evaluate the potential of cutaneous bacteria from Panamanian frogs as a possible source of compounds to treat aspergillosis and chytridiomycosis.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Sampling and bacterial isolation</title><p id="Par5">Fifteen frogs of seven species (species identified in Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>) were collected at three different sampling sites in the highlands of the Chiriqu&#x000ed; Province, Republic of Panama (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>). These species were representatives of six anuran families: Craugastoridae (6), Centrolenidae (4), Hylidae (2), Bufonidae (1), Ranidae (1) and Strabomantidae (1). A total of 439 bacterial isolates were obtained from the skin of collected frogs, representing an average of 29.3 bacterial morphotypes per frog. Among sampling sites, specimens and isolates were obtained from Volc&#x000e1;n, Fortuna Forest Reserve and La Amistad International Park with 8 frogs (250 isolates), 5 frogs (114 isolates) and 2 frogs (75 isolates), respectively (Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>).</p></sec><sec id="Sec4"><title>DNA extraction and GTG<sub>5</sub> rep-PCR fingerprinting</title><p id="Par6">After cryopreservation, we obtained 432 viable bacterial isolates, of which DNA samples were extracted. From these samples, we identified 34 clusters by GTG<sub>5</sub> rep-PCR with more than 91% band-matching similarity comprising 74% (319/432) of isolates. From these clusters, 136 isolates (4 per cluster) were selected for 16S rRNA analysis. Afterwards, we classified 25% (108/432) of samples that displayed fingerprint profiles between 70 and 90% band-matching similarities. From this last group of samples, 65 isolates were chosen for further 16S rRNA amplicon sequencing analysis (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). Finally, isolates whose fingerprint values were lower than 70%, i.e., 1% (5/432), were excluded of taxonomic identification.</p></sec><sec id="Sec5"><title>16S rRNA amplicon sequencing</title><p id="Par7">Based on the fingerprints obtained from GTG<sub>5</sub> rep-PCR analysis, 201 sequences from these strains were analyzed (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). Strains belonged to the phyla Proteobacteria, Bacteroidetes, Firmicutes and Actinobacteria with a relative abundance of 78% (164), 17% (36), 3% (6) and 2% (4), respectively. Within the phylum Proteobacteria, the most abundant families were Pseudomonadaceae (39%), Enterobacteriaceae (21%), Flavobacteriaceae (16%) and Xanthomonadaceae (10%). However, the phyla Bacteroidetes and Firmicutes included the less abundant families Comamonadaceae, Oxalobacteraceae and Bacillaceae (2%), Methylobacteriaceae (1%) and Rhizobiaceae (1%). Families of the phylum Actinobacteria had a relative abundance of less than 1% (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>Phylogenetic tree based on 16S rRNA sequences of associated-bacteria from the skin of Panamanian frogs. Color range represents bacterial phyla. Color clades show the abundance of bacterial families. The color strips relate the bacterial isolates with their host of origin. Grey color scale strips display the inhibition zones produced by bioactive bacteria against <italic>A. fumigatus</italic> ATCC 1028 after microbial interactions.</p></caption><graphic xlink:href="41598_2019_39583_Fig1_HTML" id="d29e539"/></fig></p></sec><sec id="Sec6"><title>Biological screening against <italic>A. fumigatus</italic> ATCC 1028</title><p id="Par8">We found 29 of 201 isolates that displayed considerable biological activity against <italic>A. fumigatus</italic>. Active isolates included <italic>Pseudomonas</italic> spp. (22), <italic>Bacillus</italic> spp. (5) and <italic>Chryseobacterium</italic> spp. (2). The proportion of bioactive isolates per bacterial families comprises Pseudomonadaceae: 29.33% (22/75), Bacillaceae: 89.33% (5/6) and Flavobacteriaceae: 6.25% (2/32). In terms of hosts, 44.83% (13/29) of bioactive bacteria came from the skin of <italic>Craugastor crassidigitus</italic> (Craugastoridae), 20.69% (6/29) from the skin of <italic>Craugastor melanostictus</italic> (Craugastoridae), 13.79% (4/29) from each of the skin samples of <italic>Espadarana prosoblepon</italic> (Centrolenidae) and <italic>Lithobates warszewitschii</italic> (Ranidae), and 6.90% (2/29) from the skin of <italic>Pristimantis cruentus</italic> (Craugastoridae). Five out of 7 anuran species had bacteria with activity against <italic>A. fumigatus</italic>. 73% (21/29) of bacterial isolates that displayed this activity were obtained from frogs of family Craugastoridae. However, we did not find differences in bacterial isolates with activity among host families (Fisher&#x02019;s Exact Test p&#x02009;=&#x02009;0.567). The highest values of inhibition were shown by <italic>Pseudomonas cichorii</italic> (Blast identity score 99.90%), displaying inhibition zones between 13.33&#x02009;&#x000b1;&#x02009;0.58 and 18.00&#x02009;&#x000b1;&#x02009;0.00&#x02009;mm. Such inhibition was two-fold more than the positive control cycloheximide (CHX) 9.00&#x02009;&#x000b1;&#x02009;0.00&#x02009;mm. In contrast, <italic>Pseudomonas protegens</italic> (Blast identity score 99.80%), had lower inhibition zones with values between 9.87&#x02009;&#x000b1;&#x02009;0.58 and 10.67&#x02009;&#x000b1;&#x02009;0.58&#x02009;mm (Figs&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="MOESM1" ref-type="media">S3</xref>). Both bacterial species, <italic>P. cichorii</italic> and <italic>P. protegens</italic> were isolated from the skin of <italic>C. crassidigitus</italic>.</p></sec><sec id="Sec7"><title>Agar-based imaging mass spectrometry (MALDI IMS)</title><p id="Par9">During the microbial interactions between <italic>P. cichorii</italic> and <italic>A. fumigatus</italic> ATCC 1028 we detected ten compounds specifically distributed in the inhibition zone using agar based MALDI IMS. They were detected as protonated [M&#x02009;+&#x02009;H]<sup>+</sup> and sodium adduct [M&#x02009;+&#x02009;Na]<sup>+</sup> molecular ions in the range <italic>m</italic>/<italic>z</italic> 1,110&#x02013;2,032. These ions are 1,112 [M&#x02009;+&#x02009;H]<sup>+</sup>, 1,126 [M&#x02009;+&#x02009;H]<sup>+</sup>, 1,140 [M&#x02009;+&#x02009;H]<sup>+</sup>, 1,154 [M&#x02009;+&#x02009;H]<sup>+</sup> and 2,010 [M&#x02009;+&#x02009;H]<sup>+</sup> which matched their sodium adducts with <italic>m</italic>/<italic>z</italic> 1,134 [M&#x02009;+&#x02009;Na]<sup>+</sup>, 1,148 [M&#x02009;+&#x02009;Na]<sup>+</sup>, 1,162 [M&#x02009;+&#x02009;Na]<sup>+</sup>, 1,176 [M&#x02009;+&#x02009;Na]<sup>+</sup>, and 2,032 [M&#x02009;+&#x02009;Na]<sup>+</sup>, respectively (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>MALDI IMS of microbial interaction between <italic>P. cichorii</italic> and <italic>A. fumigatus</italic> ATCC 1028. Selected ions observed for the microbial interaction are presented as columns. The first column shows mass to charge ratio, and the second to fifth columns display images of the spatial distribution of the ions produced by <italic>P. cichorii</italic>, <italic>P. cichorii</italic> vs. <italic>A. fumigatus</italic>, <italic>A. fumigatus</italic> alone, and MHA as control. The average mass spectrum highlighting selected ions is shown at the bottom. These ions were present at m/z: 1,112, 1,126, 1,134, 1,140, 1,148, 1,154, 1,162, 1,176, 2,010 and 2,032&#x02009;Da.</p></caption><graphic xlink:href="41598_2019_39583_Fig2_HTML" id="d29e693"/></fig></p></sec><sec id="Sec8"><title>MS/MS-based molecular networking</title><p id="Par10">In MS/MS networking analyses, the molecules are subjected to MS<sup>2</sup> fragmentation and are visualized as circles named nodes. The nodes are connected by edges, and the thickness of an edge indicates the similarity between the MS/MS spectra. A cluster is formed by nodes with similar MS/MS spectra, therefore they are structurally related. Identification of one compound in the cluster reveals the molecular family of the compounds.</p><p id="Par11">MS/MS molecular networking of the 29 bacterial strains with biological activity against <italic>A. fumigatus</italic> revealed 749 nodes. Among them, we focused on a specific cluster comprised of 30 nodes displaying four protonated molecules detected within the inhibition zone in the MALDI IMS experiment. These molecules were annotated as viscosin at <italic>m</italic>/<italic>z</italic> 1,125.71, massetolide F at <italic>m</italic>/<italic>z</italic> 1,126.68, massetolide A/G at <italic>m</italic>/<italic>z</italic> 1,140.74 and massetolide H at <italic>m</italic>/<italic>z</italic> 1,154. However, massetolide E at <italic>m</italic>/<italic>z</italic> 1,112.68 was not detected in samples from <italic>P. cichorii</italic>. It was detected in <italic>P. poae</italic> samples. These results indicated that this particular cluster is composed of multiple cyclic lipopeptides (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Annotation from Global Natural Products Social Molecular Networking online platform (GNPS)<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup> spectral library match and from the dereplicator tools was confirmed by detailed inspection of the fragmentation patterns observed in MS<sup>2</sup> spectra (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, Table&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p>Molecular networking of bacterial strains that displayed biological activity against <italic>A. fumigatus</italic> ATCC 1028 after 72&#x02009;hours. (<bold>a</bold>) Molecular networking of all bioactive strains against <italic>A. fumigatus</italic> ATCC 1028. Pie charts inside nodes represent the compound distribution based on the bacterial source. (<bold>b</bold>) Sub-network of cyclic lipopeptides detected inside inhibition zone through MALDI IMS. These nodes matched in GNPS spectral library. Square node comprises GNPS library hit WLIP/viscosin/massetolides molecular family and isolated viscosin from <italic>P. cichorii</italic>. massetolides A, F, G and H.</p></caption><graphic xlink:href="41598_2019_39583_Fig3_HTML" id="d29e788"/></fig><fig id="Fig4"><label>Figure 4</label><caption><p>Spectral comparison and structural fragmentation of selected lipopeptides produced by bioactive bacteria. (<bold>a</bold>) MS/MS spectra of amino acid losses for viscosin, massetolide F, A, G and H. The color of the squares represents the amino acids in the spectrum. (<bold>b</bold>) Colored structural fragmentation of viscosin, massetolides F, A, G, H and their corresponding functional groups.</p></caption><graphic xlink:href="41598_2019_39583_Fig4_HTML" id="d29e803"/></fig></p></sec><sec id="Sec9"><title>Extraction, purification and characterization of viscosin</title><p id="Par12">After growing <italic>P. cichorii</italic> on Muller Hinton Agar (MHA), organic extraction with ethyl acetate (EtOAc) enabled us to obtain 22.0&#x02009;mg of crude extract. This crude material was subsequently fractionated with a gradient of methanol (MeOH) and water (see methods). Viscosin (6.0&#x02009;mg) was obtained and purified from the fraction at 100% MeOH using high performance liquid chromatography (HPLC) separation. It was identified by NMR experiments (Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>)<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR38">38</xref></sup>. The MS/MS spectrum of viscosin displayed <italic>m</italic>/<italic>z</italic> 1,125.6968 [M&#x02009;+&#x02009;H]<sup>+</sup> and the molecular formula for this compound was calculated for C<sub>54</sub>H<sub>96</sub>N<sub>9</sub>O<sub>16</sub> with <italic>m</italic>/<italic>z</italic> 1,126.6970.</p></sec><sec id="Sec10"><title>Viscosin growth inhibition assays</title><p id="Par13">During the growth assay, we found that viscosin significantly inhibited <italic>A. fumigatus</italic> growth, compared to the positive control (t-test, p &#x02264; 0.0010) and the diluent control for every concentration tested (t-test, p &#x02264; 0.0130). Viscosin had a minimum inhibitory concentration (MIC) against <italic>A. fumigatus</italic> of 62.50 &#x003bc;g/mL (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). In addition, we found significant inhibition of <italic>B. dendrobatidis</italic> growth by viscosin when compared with the positive control (t-test, p &#x02264; 0.0013) and when evaluated with the diluent control at each concentration (t-test, p &#x02264; 0.05) (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). In this case, viscosin showed an MIC value of 31.25 &#x003bc;g/mL against <italic>B. dendrobatidis</italic>. The results shown are representative of two replicate experiments for each fungal species tested. In both cases, the MIC values were 62.50 &#x003bc;g/mL and 31.25 &#x003bc;g/mL for <italic>A. fumigatus</italic> and <italic>B. dendrobatidis</italic>, respectively (Figs&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>&#x02013;<xref rid="MOESM1" ref-type="media">S7</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>Antifungal susceptibility tests of viscosin against <italic>A. fumigatus</italic> ATCC 1028. Inhibition of growth of <italic>A. fumigatus</italic> by increasing concentrations of viscosin at 48&#x02009;hours of culture. Viscosin displayed significant inhibition (*) when comparing with the positive control (p &#x02264; 0.0068) and diluent control at each concentration (p &#x02264; 0.0001) by Student&#x02019;s t-tests. Error bars refer to the standard error of the mean. This figure is representative of two similar experiments. In both experiments, the MIC value was 62.50 &#x003bc;g/mL (Figs&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref> and <xref rid="MOESM1" ref-type="media">S5</xref>).</p></caption><graphic xlink:href="41598_2019_39583_Fig5_HTML" id="d29e910"/></fig><fig id="Fig6"><label>Figure 6</label><caption><p>Antifungal susceptibility tests of viscosin against <italic>B. dendrobatidis</italic> JEL 197. Inhibition of growth of <italic>B. dendrobatidis</italic> zoospores by increasing concentrations of viscosin at day 4 of culture. Viscosin displayed significant inhibition (*) when compared with the positive control (p &#x02264; 0.0013) and diluent control at each concentration (p &#x02264; 0.05) by Student&#x02019;s t-tests. Error bars refer to the standard error of the mean. This figure is representative of two similar experiments. In both experiments, the MIC was 31.25 &#x003bc;g/mL (Figs&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref> and <xref rid="MOESM1" ref-type="media">S7</xref>).</p></caption><graphic xlink:href="41598_2019_39583_Fig6_HTML" id="d29e932"/></fig></p></sec></sec><sec id="Sec11" sec-type="discussion"><title>Discussion</title><p id="Par14">Chytridiomycosis is a lethal disease that affects amphibians worldwide, caused by the pathogenic fungus <italic>B. dendrobatidis</italic><sup><xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Nonetheless, some amphibian species in affected areas have been shown to be able to persist in the presence of this fungus<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Although amphibians are known to produce antimicrobial peptides in the skin secretions produced by granular glands (also known as serous glands) in the dermal layer of the skin<sup><xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref></sup>, several studies have also suggested that amphibian species enduring the <italic>B. dendrobatidis</italic> outbreaks might have cutaneous bacteria that produce antifungal compounds that inhibit the growth of <italic>B. dendrobatidis</italic><sup><xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref></sup>.</p><p id="Par15">Within our sampling area of the highlands of the Chiriqu&#x000ed; Province, <italic>B. dendrobatidis</italic> has caused dramatic declines in amphibian populations<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. We collected 15 specimens from seven species to search for cutaneous bacteria with antifungal properties as a novel source of natural products. Our analysis showed that the phylum Proteobacteria is the most predominant phylum on the skin of sampled frogs as has been reported in other anuran species collected in Panama by using cultured organisms and culture-independent approaches<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. Within the phylum Proteobacteria, Pseudomonadaceae was the more abundant family; nevertheless, among the less abundant phyla (Firmicutes, Bacteroidetes and Actinobacteria) there are remarkable differences in terms of family diversity, compared to previous studies<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. Such differences could be attributable to the geographic location of sampling sites (e.g., highlands vs. lowlands, infected vs. non-infected sites), and how biotic and abiotic factors (e.g., frog species, habitat features, temperature) influence the bacterial communities on the skin of frogs<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.</p><p id="Par16">The families Pseudomonadaceae and Bacillaceae had the highest number of active bacteria against <italic>A. fumigatus</italic>. In particular, <italic>P. cichorii</italic>, isolated from the skin of <italic>C. crassidigitus</italic>, showed the strongest inhibition of <italic>A. fumigatus</italic> by agar diffusion assays. Remarkably, this inhibition was two-fold higher than our control cycloheximide (CHX)<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Afterward, we identified the molecules involved in this inhibition as cyclic lipopeptides through MALDI IMS and MS/MS molecular networking<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. Through MALDI IMS experiments, we found that cyclic lipopeptides were produced when the bacterium was cultured in both, single culture and in co-culture with the fungus. It indicates that these compounds are not secreted as consequence of the microbial interaction, more likely they could be produced with a prophylactic purpose<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. We report for the first time the presence of cyclic lipopeptides produced by skin-associated bacteria of Panamanian frogs. Among the cyclic lipopeptides produced by <italic>P. cichorii</italic>, we identified viscosin and massetolides (A, F, G, and H). Annotation of viscosin and massetolides was confirmed by conducting a detailed analysis of their MS<sup>2</sup> spectra and matching them with those reported in the literature (Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>)<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>.</p><p id="Par17">Due to the problem of emerging multidrug resistant microorganisms, there is an increasing need for new drugs from uncommon bacterial sources to treat human and animal diseases. Thus, the molecules involved in the biological activity against <italic>A. fumigatus</italic> could potentially be a novel alternative to well-known bioactive molecules such as daptomycin<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> and echinocandins (caspofungin, micafungin and anidulafungin), which have been approved by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) for use in human therapies<sup><xref ref-type="bibr" rid="CR54">54</xref>,<xref ref-type="bibr" rid="CR55">55</xref></sup>. Some of these molecules (i.e. caspofungin) exhibit inhibition of the &#x003b2;-glucan and chitin synthesis of the cell wall of <italic>A. fumigatus</italic><sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. Although, Geuden <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> reported no inhibition of <italic>A. fumigatus</italic> growth by viscosin at concentrations used in their test (i.e., lower than 32 &#x003bc;g/mL), we found that viscosin, at 62.50 &#x003bc;g/mL, inhibited the growth of <italic>A. fumigatus</italic> by 80%. Therefore, we suggest future studies on viscosin as a possible &#x003b2;-glucan and chitin biosynthesis inhibitor, considering that these are essential components of the cell wall of <italic>Aspergillus</italic> spp.<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p><p id="Par18">Viscosin was also tested <italic>in vitro</italic> against <italic>B. dendrobatidis</italic>, showing a MIC value of 31.25 &#x003bc;g/mL. Until now, there are only a few secondary metabolites chemically characterized that display inhibitory effects against <italic>B. dendrobatidis</italic>. These compounds are 2,4-diacetylphloroglucinol, indole-3-carboxaldehyde, violacein and prodiogiosin<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>. Although viscosin is known for its antibiotic effects<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup>, it had not been previously isolated from cutaneous bacteria of amphibians nor tested for effects on <italic>B. dendrobatidis</italic>. Future studies on chitin synthesis inhibition by viscosin-like lipopeptides could be an interesting subject of research, taking into account that chitin is the major component of chytridiomycete cell walls<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>. In addition, although not tested in this study, there is the potential that multiple molecules act synergistically to fend off pathogens<sup><xref ref-type="bibr" rid="CR63">63</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref></sup>. Isolation and testing of the <italic>in vitro and in vivo</italic> (using frogs inoculated with <italic>B. dendrobatidis</italic>) antifungal activity of massetolides, singly and in combination with viscosin, could be the next step of this study, since this compounds were found together at the inhibition zone of the microbial interaction, and their synergistic action might increase their biological activity.</p><p id="Par19">The data shown here support the hypothesis on the protective role mediated by cultivable bacteria that include a viscosin-producing strain, on the skin of some anurans through the production of antifungal lipopeptides. This might help to explain the resistance of some amphibian species to <italic>B. dendrobatidis</italic> infection.</p></sec><sec id="Sec12" sec-type="conclusion"><title>Conclusions</title><p id="Par20">We conclude that the family Pseudomonadaceae in the phylum Proteobacteria represents the most abundant cultivable bacterial taxa found on the skin of the frogs sampled for this study. We also found that Pseudomonadaceae and Bacillaceae were the sources of the major number of antifungal bioactive bacteria. Among these bacteria, <italic>P. cichorii</italic> displayed the highest inhibitory activity against <italic>A. fumigatus</italic>. By means of 16S rRNA sequencing, MALDI IMS and MS/MS molecular networking, it was possible to detect cyclic lipopeptides produced by <italic>P. cichorii</italic>. One of them was viscosin that displayed <italic>in vitro</italic> biological activity against both <italic>A. fumigatus</italic> and <italic>B. dendrobatidis</italic>, inhibiting their growth with MIC values 62.50 and 31.25&#x02009;&#x000b5;g/mL, respectively. This work can be used as basis for future <italic>in vivo</italic> studies treating amphibians inoculated with <italic>B. dendrobatidis</italic>. This work provides evidence on cutaneous bacteria in Panamanian frogs as an underexplored source of compounds to treat fungal diseases such as aspergillosis and chytridiomycosis.</p></sec><sec id="Sec13"><title>Methods</title><sec id="Sec14"><title>Sampling and bacterial isolation</title><p id="Par21">Fifteen frogs of seven species were collected at three localities in the highlands of the Chiriqu&#x000ed; Province, Republic of Panama (Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>, Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>). To remove transient bacteria from the skin of frogs, all specimens were rinsed with sterile water<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. After rinsing, a sterile swab was used for obtaining culture-dependent bacteria. This swab was streaked on Petri dishes containing fresh R2A agar<sup><xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref></sup> (Becton, Dickinson and Co., New Jersey, US). After sampling, the frogs were identified and released immediately at the collection place. Once bacterial colonies grew, they were characterized according to morphological features. Then, isolates were streaked on R2A agar until pure colonies were obtained. The pure isolates were cryopreserved at &#x02212;80&#x02009;&#x000b0;C in R2A broth supplemented with 15% glycerol. Sampling of bacteria used in this study was carried out under collection permit SC/AHB-1&#x02013;11 granted by the Ministry of Environment of Panama (MiAMBIENTE).</p></sec><sec id="Sec15"><title>16S rRNA amplicon sequencing</title><p id="Par22">After DNA extraction and GTG<sub>5</sub> rep-PCR fingerprinting analysis (see supplementary information), two universal primers 27&#x02009;F (5&#x02032;-AGAGTTTGATCCTGGCTCAG-3&#x02032;) and 1492&#x02009;R (5&#x02032;- GGTTACCTTGTTACGACTT-3&#x02032;) were used in PCR to amplify the 16S rRNA gene for the identification of 202 bacterial samples. The amplification reactions were carried out in 50&#x02009;&#x000b5;L (45&#x02009;&#x000b5;L of Master Mix and 5&#x02009;&#x000b5;L of bacterial DNA). The reaction mixtures were amplified at 95&#x02009;&#x000b0;C for 5&#x02009;min, followed by 30 cycles of 94&#x02009;&#x000b0;C for 1&#x02009;min, 55&#x02009;&#x000b0;C for 1&#x02009;min, 72&#x02009;&#x000b0;C for 90&#x02009;sec, and a final elongation for 10&#x02009;min. PCR products were checked by electrophoresis in Agarose gel 1%. Amplicons were sent to Macrogen Inc. (Seoul, South Korea) for Sanger sequencing. Furthermore, DNA sequences were cleaned, assembled and analyzed with Geneious 8.1.7 (Biomatters, Auckland, New Zealand)<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Additionally, a phylogenetic tree was created with Neighbor-Joining as clustering method (bootstrap of 1000 replicates). It was exported from Geneious (Newick format) and imported to the online platform ITOL for data visualization<sup><xref ref-type="bibr" rid="CR72">72</xref>,<xref ref-type="bibr" rid="CR73">73</xref></sup>. The final tree is available at (<ext-link ext-link-type="uri" xlink:href="https://itol.embl.de/tree/20046278967671452714596">https://itol.embl.de/tree/20046278967671452714596#</ext-link>). The 16S taxonomic diversity was obtained from the Ribosomal Database Project (RDP) and BLASTn. Sequences are available in GenBank with accession codes KX456226-KX456434.</p></sec><sec id="Sec16"><title>Agar-based imaging mass spectrometry (MALDI IMS)</title><p id="Par23">MALDI IMS was conducted after screening all bacteria against <italic>A. fumigatus</italic> (see supplementary information). The most bioactive bacteria were analyzed by using a thin layer of Mueller Hinton agar (MHA). Individually, Petri dishes had: 1) bacterial colony of <italic>P. cichorii</italic>, 2) microbial interaction of <italic>P. cichorii</italic> vs. <italic>A. fumigatus</italic>, 3) <italic>A. fumigatus</italic> ATCC 1028 and 4) MHA as control. The agar in Petri dishes was cut and placed onto a ground steel MALDI MTP plate (Bruker Daltonics, Billerica, MA, USA). This MALDI plate was covered with the universal MALDI matrix (1 &#x003b1;-Cyano-4-hydroxycinnamic acid HCCA 1:1 mixture, Sigma Aldrich Catalog 50149) by a dry deposition method using a molecular sieve of 44 &#x003bc;m and dried overnight at 37&#x02009;&#x000b0;C. A photograph was taken before and after adding/drying universal MALDI<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. MALDI IMS was conducted using an UltrafleXtreme mass spectrometer (Bruker, Bremen, Germany) for mass spectra acquisition. Samples were run in positive reflector mode at 500 &#x003bc;m laser intervals in XY and a mass range of 100&#x02013;3000&#x02009;Da. Results were analyzed by FlexImaging 3.0 software (Bruker). Images of interesting ions were color-generated, exported and organized using ImageJ 1.47&#x02009;V software (NIH, Bethesda, MD).</p></sec><sec id="Sec17"><title>MS/MS-based molecular networks</title><p id="Par24">Organic extracts from bioactive bacteria were analyzed through liquid chromatography-tandem mass spectrometry (LC-MS/MS) experiments by electrospray ionization quadrupole-time of flight mass spectrometry (ESI-Q-TOF-MS) in a micrOTOF-QIII mass spectrometer (Bruker). The liquid chromatography method selected for analysis was conducted in a 1290 Infinity UHPLC equipment (Agilent Technologies, Santa Clara, CA), using a KINETEX reverse phase column with C-18 chemistry, 50&#x02009;mm&#x02009;&#x000d7;&#x02009;2.1&#x02009;mm and 1.7 &#x003bc;m particle size (Phenomenex, Torrance, CA). The mobile phase was 0.1% formic acid in Milli-Q water in channel A and methanol in channel B. Liquid chromatography runs were performed with a gradient of 10 to 100% B in 7&#x02009;min with additional isocratic 100% B for 9&#x02009;min. Mass spectrometry data were acquired in positive ion mode with a detection range of 50&#x02013;2250&#x02009;m/z using data dependent MS/MS fragmentation<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>.</p><p id="Par25">Molecular networks were generated using the Global Natural Products Social Molecular Networking online platform (GNPS)<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR76">76</xref></sup>. The MZmine workflow for feature based molecular networking on GNPS was used to perform feature detection, grouping, and alignment<sup><xref ref-type="bibr" rid="CR77">77</xref>,<xref ref-type="bibr" rid="CR78">78</xref></sup> (see supplementary methods). MS-Clustering was turned off, and a spectral library search was performed using 0.02&#x02009;Da for ion mass and fragment ion tolerance. A cosine score for getting spectral matching with MS/MS spectral libraries was set at 0.70. A minimum of four matching peaks was considered for spectral library annotations. The resulting molecular network is available at <ext-link ext-link-type="uri" xlink:href="https://proteomics2.ucsd.edu/ProteoSAFe/status.jsp?task=cbd4d0d6e4b34a05a0e29ec542750d5a">https://proteomics2.ucsd.edu/ProteoSAFe/status.jsp?task&#x02009;=&#x02009;cbd4d0d6e4b34a05a0e29ec542750d5a</ext-link>. This network was imported to Cytoscape version 3.5.0 (<ext-link ext-link-type="uri" xlink:href="http://www.cytoscape.org">www.cytoscape.org</ext-link>) and analyzed using default algorithms and other visual considerations. An ion mass tolerance and a fragment ion mass tolerance of 0.02&#x02009;Da were used. The number of minimum amino acids was set to five. The dereplication process was achieved by searching MS/MS spectra into GNPS libraries. This result was imported in the network generated in Cytoscape 3.5.0. The MS/MS spectra of annotated compounds are publicly accessible at GNPS library through the accession numbers: CCMSLIB00000579932, CCMSLIB00000579933, CCMSLIB00003742128 and CCMSLIB00000579934. Dataset is available in Massive (MSV000082747) at <ext-link ext-link-type="uri" xlink:href="https://massive.ucsd.edu/ProteoSAFe/status.jsp?task=ef5e14c452ee403eb1d69cfae55a8895">https://massive.ucsd.edu/ProteoSAFe/status.jsp?task&#x02009;=&#x02009;ef5e14c452ee403eb1d69cfae55a8895</ext-link>.</p></sec><sec id="Sec18"><title>Extraction, purification and characterization of viscosin</title><p id="Par26">To identify ions of interest detected in MALDI IMS experiments, <italic>P. cichorii</italic> was grown in single culture using 30 square dishes (120&#x02009;&#x000d7;&#x02009;120&#x02009;mm) continaing MHA for 72&#x02009;hours at room temperature. Agar was cut in strips and placed into 2000 mL Erlenmeyer flasks for maceration with ethyl acetate (EtOAc) for 24&#x02009;hours. Strips were extracted with EtOAc (3&#x02009;&#x000d7;&#x02009;500&#x02009;mL) and resuspended in methanol (MeOH) for fractionation and MS analysis.</p><p id="Par27">The extract obtained was fractionated using a Superclean LC 18 cartridge (Catalog 57136, Supelco Analytical, Sigma-Aldrich) eluted with 20%, 40%, 60%, 80% and 100% of MeOH in H<sub>2</sub>O<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. Afterwards, each fraction and crude extract was analyzed in LC-MS/MS for detection of the presence of lipopeptides.</p><p id="Par28">Compound separation was carried out on Agilent 1100 HPLC. Fraction E (100% MeOH) was injected in a Synergi 4&#x02009;u Polar C18 semi-preparative column (250&#x02009;&#x000d7;&#x02009;10&#x02009;mm) of 4&#x02009;&#x000b5;m particle size (Phenomenex, Torrance, CA) applying a gradient elution method from 80:100% MeOH/H<sub>2</sub>O in 30&#x02009;min, and operating at 1&#x02009;mL/min with a diode array detector (DAD) set for single-wavelength detection at 254&#x02009;nm. The peak of interest was re-injected into the same column with a gradient elution from 50:50 to 100% acetonitrile/water in 20&#x02009;min with 0.1% trifluoroacetic acid (TFA), and operating at 4.2&#x02009;mL/min with a DAD set for single-wavelength detection at 214&#x02009;nm<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. NMR spectra of the sample were obtained in a Jeol Eclipse 400&#x02009;MHz spectrometer and referenced to residual solvent <sup>1</sup>H and <sup>13</sup>C signals (&#x003b4;<sub>H</sub> 3.31, 4.87 and &#x003b4;<sub>C</sub> 49.15 for C).</p></sec><sec id="Sec19"><title>Viscosin growth inhibition assays</title><p id="Par29">Viscosin was evaluated against <italic>A. fumigatus</italic> in a range of 0.4 to 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> CFU/mL, according to the reference method for broth dilution antifungal susceptibility testing of filamentous fungi<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>. The final concentration of viscosin in the wells ranged from 3.90 to 500&#x02009;&#x000b5;g/mL. The trays were incubated at 35&#x02009;&#x000b0;C, and read after 48&#x02009;hours at 490&#x02009;nm (O.D.<sub>490</sub>)<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>.</p><p id="Par30">In the case of <italic>B. dendrobatidis</italic>, mixed zoosporangia and zoospores of isolate JEL197 were plated onto 1% tryptone agar plates, and cultured at 21&#x02009;&#x000b0;C for 3 days. Zoospores were purified by twice flooding the agar with sterile 1% tryptone broth<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. The broth containing zoospores was filtered with a 20&#x02009;&#x000b5;m mesh opening filter, and isolated zoospores were resuspended in 1% tryptone broth at a concentration of 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup>/mL. Freshly isolated zoospores were plated in five replicate wells (5&#x02009;&#x000d7;&#x02009;10<sup>4</sup>/50&#x02009;&#x000b5;L) in 1% tryptone broth with 50&#x02009;&#x000b5;l of a serially diluted viscosin at concentrations in culture ranging from 3.9&#x02009;&#x000b5;g/mL to 250&#x02009;&#x000b5;g/mL. The plates were incubated at 21&#x02009;&#x000b0;C for four or seven days, and growth was measured as an increase in optical density at 490&#x02009;nm (O.D.<sub>490</sub>)<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>.</p><p id="Par31">For these assays, viscosin (1.1&#x02009;mg) was dissolved in 100&#x02009;&#x000b5;L of 70% ethanol. The viscosin was resuspended in a total volume of 1.1&#x02009;mL with sterile water plus penicillin (100 I.U/mL) and streptomycin (100&#x02009;&#x000b5;g/mL) to equal a stock suspension of 1&#x02009;mg/mL. The stock was further diluted serially with sterile water and antibiotics to 500, 250, 125, 62.5, 31.25, 15.6, 7.8 and 3.9&#x02009;&#x000b5;g/mL, and 50&#x02009;&#x000b5;L of each dilution (five replicates) was added to 50&#x02009;&#x000b5;L of target fungi. To determine the possible effects of the ethanol diluent, serial dilutions were prepared without viscosin, and fungi were cultured independently with each dilution of ethanol. Ethanol concentrations ranged from 0.03 to 1.75%. Positive control wells (without viscosin or ethanol) contained fungi and 50&#x02009;&#x000b5;L of sterile water plus antibiotics. Negative control wells contained 50&#x02009;&#x000b5;L of heat-killed fungi (10&#x02009;min at 60&#x02009;&#x000b0;C for <italic>B. dendrobatidis</italic> and 100&#x02009;&#x000b0;C for <italic>A. fumigatus</italic>) and 50&#x02009;&#x000b5;L of sterile water plus antibiotics.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec20"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_39583_MOESM1_ESM.pdf"><caption><p>Viscosin-like lipopeptides from frog skin bacteria inhibit Aspergillus fumigatus and Batrachochytrium dendrobatidis detected by imaging mass spectrometry and molecular networking</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Electronic supplementary material</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-019-39583-7.</p></sec><ack><title>Acknowledgements</title><p>We are grateful to the Ministerio de Ambiente of Panama for granting permission (SC/AHB-1-11, SEX/AH-3-17) for collecting and for exporting samples. We thank Javier Ballesteros and Joel S&#x000e1;nchez for their support during sampling frogs. We thank Librada Atencio, Gianinna Ow Young, Ricardo Santamar&#x000ed;a and Juan Rojas for their support in the microbiology and chemistry Labs. This project was partially supported by the National Secretariat for Science and Technology of Panama (SENACYT) through INDICASAT (IND-JAL-05) and the Global Environment Facility (GEF ID 4780&#x02013;UNDP 81860). CM is supported by a scholarship from SENACYT and the Instituto para la Formaci&#x000f3;n y Aprovechamiento de Recursos Humanos (IFARHU). CM, RI and MG are thankful for the support of the National System of Research (SNI) of Panama. RI was also supported by the Panama Amphibian Rescue and Conservation Project, and Cobre Panam&#x000e1;. Experiments conducted in the Rollins-Smith laboratory were supported by a National Science Foundation (USA) grant IOS-1557634.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>M.G., R.I. and C.M. designed the project. C.M. and R.I. collected frogs for this study. C.M. performed bacterial isolation. C.M. performed GTG<sub>5</sub> rep-PCR data acquisition and data analysis. C.M. performed bacterial DNA sequencing for taxonomic identification. C.M. executed <italic>in vitro</italic> bioassays against <italic>A. fumigatus</italic>. C.M. and C.B. performed sample preparation, data acquisition and analysis for MALDI IMS. C.M. and L.-F.N. analyzed LC-MS experiments and generated molecular networking. L.R.-S. and L.R. performed and analyzed <italic>B. dendrobatidis</italic> antagonistic experiments. C.M., R.I., L.-F.N., P.D., L.R.-S. and M.G. wrote the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>All data generated or analyzed during this study are included in this article and in it supporting information files. Acquired MS data is deposited in the GNPS MassIVE repository under the accession number: MSV000082747 (see link in methods). Additionally, all sequences are deposited in Genbank under the accession codes KX456226-KX456434.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p>The authors declare no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>L</given-names></name><etal/></person-group><article-title>Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>9031</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.15.9031</pub-id><pub-id pub-id-type="pmid">9671799</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Berger, L., Speare, R. &#x00026; Hyatt, A. Chytrid fungi and amphibian declines: Overview, implications and future directions. <italic>Environ. Aust. Canberra</italic> 23&#x02013;33 (1999).</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pessier</surname><given-names>AP</given-names></name><name><surname>Nichols</surname><given-names>DK</given-names></name><name><surname>Longcore</surname><given-names>JE</given-names></name><name><surname>Fuller</surname><given-names>MS</given-names></name></person-group><article-title>Cutaneous chytridiomycosis in poison dart frogs (<italic>Dendrobates</italic> spp.) and White&#x02019;s tree frogs (<italic>Litoria caerulea</italic>)</article-title><source>J. Vet. Diagn. Invest.</source><year>1999</year><volume>11</volume><fpage>194</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1177/104063879901100219</pub-id><pub-id pub-id-type="pmid">10098698</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martel</surname><given-names>A</given-names></name><etal/></person-group><article-title><italic>Batrachochytrium salamandrivorans</italic> sp. nov. causes lethal chytridiomycosis in amphibians</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>15325</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.1307356110</pub-id><pub-id pub-id-type="pmid">24003137</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lips</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Emerging infectious disease and the loss of biodiversity in a Neotropical amphibian community</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>3165</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506889103</pub-id><pub-id pub-id-type="pmid">16481617</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beernaert</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Avian <italic>Aspergillus fumigatus</italic> strains resistant to both itraconazole and voriconazole</article-title><source>Antimicrob. Agents Chemother.</source><year>2009</year><volume>53</volume><fpage>2199</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1128/AAC.01492-08</pub-id><pub-id pub-id-type="pmid">19258265</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beernaert</surname><given-names>LA</given-names></name><name><surname>Pasmans</surname><given-names>F</given-names></name><name><surname>Van Waeyenberghe</surname><given-names>L</given-names></name><name><surname>Haesebrouck</surname><given-names>F</given-names></name><name><surname>Martel</surname><given-names>A</given-names></name></person-group><article-title><italic>Aspergillus</italic> infections in birds: a review</article-title><source>Avian Pathol.</source><year>2010</year><volume>39</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1080/03079457.2010.506210</pub-id><pub-id pub-id-type="pmid">20954008</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arn&#x000e9;</surname><given-names>P</given-names></name><etal/></person-group><article-title><italic>Aspergillus fumigatus</italic> in poultry</article-title><source>Int. J. Microbiol.</source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1155/2011/746356</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanafani</surname><given-names>ZA</given-names></name><name><surname>Perfect</surname><given-names>JR</given-names></name></person-group><article-title>Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact</article-title><source>Clin. Infect. Dis.</source><year>2008</year><volume>46</volume><fpage>120</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1086/524071</pub-id><pub-id pub-id-type="pmid">18171227</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latg&#x000e9;</surname><given-names>JP</given-names></name></person-group><article-title><italic>Aspergillus fumigatus</italic> and aspergillosis</article-title><source>Clin. Microbiol. Rev.</source><year>1999</year><volume>12</volume><fpage>310</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1128/CMR.12.2.310</pub-id><pub-id pub-id-type="pmid">10194462</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>C-Y</given-names></name><name><surname>Rotstein</surname><given-names>C</given-names></name></person-group><article-title>Emerging fungal infections in immunocompromised patients</article-title><source>F1000 Med. Rep.</source><year>2011</year><volume>3</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.3410/M3-14</pub-id><pub-id pub-id-type="pmid">21876720</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maschmeyer</surname><given-names>G</given-names></name></person-group><article-title>The changing epidemiology of invasive fungal infections: new threats</article-title><source>Int. J. Antimicrob. Agents</source><year>2006</year><volume>27</volume><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2006.03.006</pub-id><pub-id pub-id-type="pmid">16707250</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voyles</surname><given-names>J</given-names></name><etal/></person-group><article-title>Shifts in disease dynamics in a tropical amphibian assemblage are not due to pathogen attenuation</article-title><source>Science (80-.).</source><year>2018</year><volume>359</volume><fpage>1517</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1126/science.aao4806</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Rollins-Smith, L. A. &#x00026; Woodhams, D. C. In <italic>Ecoimmunology</italic> (eds Demas, G. E. &#x00026; Nelson, R. J.) 92&#x02013;143 (Oxford University Press, USA, 2012).</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodhams</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Symbiotic bacteria contribute to innate immune defenses of the threatened mountain yellow-legged frog</article-title><source>Rana muscosa. Biol. Conserv.</source><year>2007</year><volume>138</volume><fpage>390</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/j.biocon.2007.05.004</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins-Smith</surname><given-names>LA</given-names></name><name><surname>Conlon</surname><given-names>JM</given-names></name></person-group><article-title>Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations</article-title><source>Dev. Comp. Immunol.</source><year>2005</year><volume>29</volume><fpage>589</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2004.11.004</pub-id><pub-id pub-id-type="pmid">15784290</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Phylogenetic distribution of symbiotic bacteria from Panamanian amphibians that inhibit growth of the lethal fungal pathogen <italic>Batrachochytrium dendrobatidis</italic></article-title><source>Mol. Ecol.</source><year>2015</year><volume>24</volume><fpage>1628</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1111/mec.13135</pub-id><pub-id pub-id-type="pmid">25737297</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bletz</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Mitigating amphibian chytridiomycosis with bioaugmentation: Characteristics of effective probiotics and strategies for their selection and use</article-title><source>Ecol. Lett.</source><year>2013</year><volume>16</volume><fpage>807</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1111/ele.12099</pub-id><pub-id pub-id-type="pmid">23452227</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebollar</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Skin bacterial diversity of Panamanian frogs is associated with host susceptibility and presence of <italic>Batrachochytrium dendrobatidis</italic></article-title><source>ISME J.</source><year>2016</year><volume>10</volume><fpage>1682</fpage><lpage>1695</lpage><pub-id pub-id-type="doi">10.1038/ismej.2015.234</pub-id><pub-id pub-id-type="pmid">26744810</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RN</given-names></name><name><surname>James</surname><given-names>TY</given-names></name><name><surname>Lauer</surname><given-names>A</given-names></name><name><surname>Simon</surname><given-names>MA</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name></person-group><article-title>Amphibian pathogen <italic>Batrachochytrium dendrobatidis</italic> is inhibited by the cutaneous bacteria of amphibian species</article-title><source>Ecohealth</source><year>2006</year><volume>3</volume><fpage>53</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s10393-005-0009-1</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodhams</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Prodigiosin, violacein, and volatile organic compounds produced by widespread cutaneous bacteria of amphibians can inhibit two Batrachochytrium fungal pathogens</article-title><source>Microb. Ecol.</source><year>2018</year><volume>75</volume><fpage>1049</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1007/s00248-017-1095-7</pub-id><pub-id pub-id-type="pmid">29119317</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>MH</given-names></name><name><surname>Brucker</surname><given-names>RM</given-names></name><name><surname>Schwantes</surname><given-names>CR</given-names></name><name><surname>Harris</surname><given-names>RN</given-names></name><name><surname>Minbiole</surname><given-names>KPC</given-names></name></person-group><article-title>The bacterially produced metabolite violacein is associated with survival of amphibians infected with a lethal fungus</article-title><source>Appl. Environ. Microbiol.</source><year>2009</year><volume>75</volume><fpage>6635</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1128/AEM.01294-09</pub-id><pub-id pub-id-type="pmid">19717627</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brucker</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Amphibian chemical defense: antifungal metabolites of the microsymbiont <italic>Janthinobacterium lividum</italic> on the salamander <italic>Plethodon cinereus</italic></article-title><source>J. Chem. Ecol.</source><year>2008</year><volume>34</volume><fpage>1422</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s10886-008-9555-7</pub-id><pub-id pub-id-type="pmid">18949519</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanglard</surname><given-names>D</given-names></name></person-group><article-title>Emerging Threats in Antifungal-Resistant Fungal Pathogens</article-title><source>Front. Med.</source><year>2016</year><volume>3</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.3389/fmed.2016.00011</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Roemer, T. &#x00026; Krysan, D. J. Antifungal drug development: challenges, unmet clinical needs, and new approaches. <italic>Cold Spring Harb. Perspect. Med</italic>. <bold>4</bold> (2014).</mixed-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Sheng</surname><given-names>C</given-names></name></person-group><article-title>Strategies in the discovery of novel antifungal scaffolds</article-title><source>Future Med. Chem.</source><year>2016</year><volume>8</volume><fpage>1435</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.4155/fmc-2016-0020</pub-id><pub-id pub-id-type="pmid">27463376</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raaijmakers</surname><given-names>JM</given-names></name><name><surname>de Bruijn</surname><given-names>I</given-names></name><name><surname>Nybroe</surname><given-names>O</given-names></name><name><surname>Ongena</surname><given-names>M</given-names></name></person-group><article-title>Natural functions of lipopeptides from Bacillus and Pseudomonas: More than surfactants and antibiotics</article-title><source>FEMS Microbiol. Rev.</source><year>2010</year><volume>34</volume><fpage>1037</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2010.00221.x</pub-id><pub-id pub-id-type="pmid">20412310</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerard</surname><given-names>J</given-names></name><etal/></person-group><article-title>Massetolides A-H, antimycobacterial cyclic depsipeptides produced by two pseudomonads isolated from marine habitats</article-title><source>J. Nat. Prod.</source><year>1997</year><volume>60</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1021/np9606456</pub-id><pub-id pub-id-type="pmid">9157190</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esquenazi</surname><given-names>E</given-names></name><etal/></person-group><article-title>Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging</article-title><source>Mol. Biosyst.</source><year>2008</year><volume>4</volume><fpage>562</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1039/b720018h</pub-id><pub-id pub-id-type="pmid">18493654</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornett</surname><given-names>DS</given-names></name><name><surname>Reyzer</surname><given-names>ML</given-names></name><name><surname>Chaurand</surname><given-names>P</given-names></name><name><surname>Caprioli</surname><given-names>RM</given-names></name></person-group><article-title>MALDI imaging mass spectrometry: molecular snapshots of biochemical systems</article-title><source>Nat. Methods</source><year>2007</year><volume>4</volume><fpage>828</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1038/nmeth1094</pub-id><pub-id pub-id-type="pmid">17901873</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W-T</given-names></name><name><surname>Kersten</surname><given-names>RD</given-names></name><name><surname>Yang</surname><given-names>Y-L</given-names></name><name><surname>Moore</surname><given-names>BS</given-names></name><name><surname>Dorrestein</surname><given-names>PC</given-names></name></person-group><article-title>Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in <italic>Streptomyces roseosporus</italic></article-title><source>J. Am. Chem. Soc.</source><year>2011</year><volume>133</volume><fpage>18010</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1021/ja2040877</pub-id><pub-id pub-id-type="pmid">21999343</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Molecular networking as a drug discovery, drug metabolism, and precision medicine strategy</article-title><source>Trends Pharmacol. Sci.</source><year>2017</year><volume>38</volume><fpage>143</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2016.10.011</pub-id><pub-id pub-id-type="pmid">27842887</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohimani</surname><given-names>H</given-names></name><etal/></person-group><article-title>Dereplication of peptidic natural products through database search of mass spectra</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>30</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2219</pub-id><pub-id pub-id-type="pmid">27820803</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watrous</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mass spectral molecular networking of living microbial colonies</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>E1743</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1073/pnas.1203689109</pub-id><pub-id pub-id-type="pmid">22586093</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking</article-title><source>Nat. Biotechnol.</source><year>2016</year><volume>34</volume><fpage>828</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nbt.3597</pub-id><pub-id pub-id-type="pmid">27504778</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>H</given-names></name><etal/></person-group><article-title>The genomisotopic approach: A systematic method to isolate products of orphan biosynthetic gene clusters</article-title><source>Chem. Biol.</source><year>2007</year><volume>14</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2006.11.007</pub-id><pub-id pub-id-type="pmid">17254952</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geudens</surname><given-names>N</given-names></name><etal/></person-group><article-title>Impact of a stereocentre inversion in cyclic lipodepsipeptides from the viscosin group: A comparative study of the viscosinamide and pseudodesmin conformation and self-assembly</article-title><source>ChemBioChem</source><year>2014</year><volume>15</volume><fpage>2736</fpage><lpage>2746</lpage><pub-id pub-id-type="doi">10.1002/cbic.201402389</pub-id><pub-id pub-id-type="pmid">25382202</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laycock</surname><given-names>MV</given-names></name><name><surname>Hildebrand</surname><given-names>PD</given-names></name><name><surname>Thibault</surname><given-names>P</given-names></name><name><surname>Walter</surname><given-names>JA</given-names></name><name><surname>Wright</surname><given-names>JLC</given-names></name></person-group><article-title>Viscosin, a potent peptidolipid biosurfactant and phytopathogenic mediator produced by a pectolytic strain of <italic>Pseudomonas fluorescens</italic></article-title><source>J. Agric. Food Chem.</source><year>1991</year><volume>39</volume><fpage>483</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1021/jf00003a011</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolas</surname><given-names>P</given-names></name><name><surname>Mor</surname><given-names>A</given-names></name></person-group><article-title>Peptides as weapons against microorganisms in the chemical defense system of vertebrates</article-title><source>Annu. Rev. Microbiol.</source><year>1995</year><volume>49</volume><fpage>277</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.49.100195.001425</pub-id><pub-id pub-id-type="pmid">8561461</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmaco</surname><given-names>M</given-names></name><name><surname>Mignogna</surname><given-names>G</given-names></name><name><surname>Barra</surname><given-names>D</given-names></name></person-group><article-title>Antimicrobial peptides from amphibian skin: what do they tell us?</article-title><source>Biopolymers</source><year>1998</year><volume>47</volume><fpage>435</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0282(1998)47:6&#x0003c;435::AID-BIP3&#x0003e;3.0.CO;2-8</pub-id><pub-id pub-id-type="pmid">10333736</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zasloff</surname><given-names>M</given-names></name></person-group><article-title>Antimicrobial peptides of multicellular organisms</article-title><source>Nature</source><year>2002</year><volume>415</volume><fpage>389</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/415389a</pub-id><pub-id pub-id-type="pmid">11807545</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>AC</given-names></name></person-group><article-title>Antimicrobial peptides from amphibian skin: an expanding scenario</article-title><source>Curr. Opin. Chem. Biol.</source><year>2002</year><volume>6</volume><fpage>799</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/S1367-5931(02)00401-5</pub-id><pub-id pub-id-type="pmid">12470734</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>JM</given-names></name><name><surname>Kolodziejek</surname><given-names>J</given-names></name><name><surname>Nowotny</surname><given-names>N</given-names></name></person-group><article-title>Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents</article-title><source>Biochim. Biophys. Acta</source><year>2004</year><volume>1696</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2003.09.004</pub-id><pub-id pub-id-type="pmid">14726199</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apponyi</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance</article-title><source>Peptides</source><year>2004</year><volume>25</volume><fpage>1035</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1016/j.peptides.2004.03.006</pub-id><pub-id pub-id-type="pmid">15203252</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lips</surname><given-names>KR</given-names></name></person-group><article-title>Mass mortality and population declines of anurans at an upland site in Western Panama</article-title><source>Conserv. Biol.</source><year>1999</year><volume>13</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1046/j.1523-1739.1999.97185.x</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lips</surname><given-names>KR</given-names></name></person-group><article-title>Decline of a tropical montane amphibian fauna</article-title><source>Conserv. Biol.</source><year>2008</year><volume>12</volume><fpage>106</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1739.1998.96359.x</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belden</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Panamanian frog species host unique skin bacterial communities</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.01171</pub-id><pub-id pub-id-type="pmid">25653648</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>MH</given-names></name><name><surname>Richards-Zawacki</surname><given-names>CL</given-names></name><name><surname>Gratwicke</surname><given-names>B</given-names></name><name><surname>Belden</surname><given-names>LK</given-names></name></person-group><article-title>The effect of captivity on the cutaneous bacterial community of the critically endangered Panamanian golden frog (<italic>Atelopus zeteki</italic>)</article-title><source>Biol. Conserv.</source><year>2014</year><volume>176</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.biocon.2014.05.029</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belden</surname><given-names>LK</given-names></name><name><surname>Harris</surname><given-names>RN</given-names></name></person-group><article-title>Infectious diseases in wildlife: the community ecology context</article-title><source>Front. Ecol. Environ.</source><year>2007</year><volume>5</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1890/060122</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarai</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The <italic>in-vitro</italic> evaluation of antibacterial, antifungal and cytotoxic properties of <italic>Marrubium vulgare</italic> L. essential oil grown in Tunisia</article-title><source>Lipids Health Dis.</source><year>2011</year><volume>10</volume><fpage>161</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-10-161</pub-id><pub-id pub-id-type="pmid">21936887</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boya P.</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Imaging mass spectrometry and MS/MS molecular networking reveals chemical interactions among cuticular bacteria and pathogenic fungi associated with fungus-growing ants</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>5604</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-05515-6</pub-id><pub-id pub-id-type="pmid">28717220</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolker-Nielsen</surname><given-names>T</given-names></name><etal/></person-group><article-title>Lipopeptide biosurfactant viscosin enhances dispersal of <italic>Pseudomonas fluorescens</italic> SBW25 biofilms</article-title><source>Microbiology</source><year>2015</year><volume>161</volume><fpage>2289</fpage><lpage>2297</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000191</pub-id><pub-id pub-id-type="pmid">26419730</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeu</surname><given-names>L</given-names></name><name><surname>Fung</surname><given-names>HB</given-names></name></person-group><article-title>Daptomycin: A cyclic lipopeptide antimicrobial agent</article-title><source>Clin. Ther.</source><year>2004</year><volume>26</volume><fpage>1728</fpage><lpage>1757</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2004.11.014</pub-id><pub-id pub-id-type="pmid">15639687</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>G</given-names></name><name><surname>Ierodiakonou</surname><given-names>V</given-names></name><name><surname>Falagas</surname><given-names>ME</given-names></name></person-group><article-title>Lost in translation: Differences in antimicrobial indication approval policies between the United States and Europe</article-title><source>Clin. Ther.</source><year>2009</year><volume>31</volume><fpage>1595</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2009.06.016</pub-id><pub-id pub-id-type="pmid">19695409</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kofla</surname><given-names>G</given-names></name><name><surname>Ruhnke</surname><given-names>M</given-names></name></person-group><article-title>Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature</article-title><source>Eur. J. Med. Res.</source><year>2011</year><volume>16</volume><fpage>159</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1186/2047-783X-16-4-159</pub-id><pub-id pub-id-type="pmid">21486730</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denning</surname><given-names>DW</given-names></name></person-group><article-title>Echinocandin antifungal drugs</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>1142</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)14472-8</pub-id><pub-id pub-id-type="pmid">14550704</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verwer</surname><given-names>PEB</given-names></name><name><surname>Van Duijn</surname><given-names>ML</given-names></name><name><surname>Tavakol</surname><given-names>M</given-names></name><name><surname>Bakker-Woudenberg</surname><given-names>IAJM</given-names></name><name><surname>Van De Sande</surname><given-names>WWJ</given-names></name></person-group><article-title>Reshuffling of <italic>Aspergillus fumigatus</italic> cell wall components chitin and &#x003b2;-glucan under the influence of caspofungin or nikkomycin Z alone or in combination</article-title><source>Antimicrob. Agents Chemother.</source><year>2012</year><volume>56</volume><fpage>1595</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1128/AAC.05323-11</pub-id><pub-id pub-id-type="pmid">22203603</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geudens</surname><given-names>N</given-names></name><etal/></person-group><article-title>Membrane interactions of natural cyclic lipodepsipeptides of the viscosin group</article-title><source>Biochim. Biophys. Acta - Biomembr.</source><year>2017</year><volume>1859</volume><fpage>331</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2016.12.013</pub-id><pub-id pub-id-type="pmid">28007479</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>Ba</given-names></name><name><surname>Walton</surname><given-names>DB</given-names></name><name><surname>Harris</surname><given-names>RN</given-names></name></person-group><article-title>Motile zoospores of <italic>Batrachochytrium dendrobatidis</italic> move away from antifungal metabolites produced by amphibian skin bacteria</article-title><source>Ecohealth</source><year>2011</year><volume>8</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s10393-011-0689-7</pub-id><pub-id pub-id-type="pmid">21769695</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>T</given-names></name><name><surname>H&#x000e4;rtner</surname><given-names>T</given-names></name><name><surname>Poralla</surname><given-names>K</given-names></name></person-group><article-title>Surface active properties of viscosin: a peptidolipid antibiotic</article-title><source>Appl. Microbiol. Biotechnol.</source><year>1990</year><volume>32</volume><fpage>518</fpage><lpage>520</lpage></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartnicki-Garcia</surname><given-names>S</given-names></name></person-group><article-title>Cell Wall Chemistry, Morphogenesis, and Taxonomy of Fungi</article-title><source>Annu. Rev. Microbiol.</source><year>1968</year><volume>22</volume><fpage>87</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.22.100168.000511</pub-id><pub-id pub-id-type="pmid">4879523</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroh</surname><given-names>M</given-names></name><name><surname>Hendriks</surname><given-names>H</given-names></name><name><surname>Kirby</surname><given-names>EG</given-names></name><name><surname>Sassen</surname><given-names>MM</given-names></name></person-group><article-title>Cell wall formation in zoospores of Allomyces arbuscula. II. Development of surface structure of encysted haploid zoospores, rhizoids, and hyphae</article-title><source>Arch. Microbiol.</source><year>1976</year><volume>109</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/BF00425110</pub-id><pub-id pub-id-type="pmid">986794</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Synergistic inhibition of the lethal fungal pathogen Batrachochytrium dendrobatidis: the combined effect of symbiotic bacterial metabolites and antimicrobial peptides of the frog <italic>Rana muscosa</italic></article-title><source>J. Chem. Ecol.</source><year>2012</year><volume>38</volume><fpage>958</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/s10886-012-0170-2</pub-id><pub-id pub-id-type="pmid">22914957</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Loudon, A. H. <italic>et al</italic>. Interactions between amphibians&#x02019; symbiotic bacteria cause the production of emergent anti-fungal metabolites. <italic>Front. Microbiol</italic>. <bold>5</bold> (2014).</mixed-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryder</surname><given-names>NS</given-names></name><name><surname>Leitner</surname><given-names>I</given-names></name></person-group><article-title>Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species</article-title><source>Med. Mycol.</source><year>2001</year><volume>39</volume><fpage>91</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1080/mmy.39.1.91.95</pub-id><pub-id pub-id-type="pmid">11270414</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ami</surname><given-names>R</given-names></name><name><surname>Lewis</surname><given-names>RE</given-names></name><name><surname>Kontoyiannis</surname><given-names>DP</given-names></name></person-group><article-title><italic>In vitro</italic> interactions among echinocandins against <italic>Aspergillus fumigatus</italic>: lack of concordance among methods</article-title><source>Med. Mycol.</source><year>2011</year><volume>49</volume><fpage>285</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.3109/13693786.2010.530300</pub-id><pub-id pub-id-type="pmid">21028945</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stergiopoulou</surname><given-names>T</given-names></name><etal/></person-group><article-title>Synergistic Interaction of the Triple Combination of Amphotericin B, Ciprofloxacin, and Polymorphonuclear Neutrophils against <italic>Aspergillus fumigatus</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2011</year><volume>55</volume><fpage>5923</fpage><lpage>5929</lpage><pub-id pub-id-type="doi">10.1128/AAC.00548-11</pub-id><pub-id pub-id-type="pmid">21911564</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Walke, J. B. <italic>et al</italic>. Amphibian skin may select for rare environmental microbes. <italic>ISME J</italic>. 1&#x02013;11, 10.1038/ismej.2014.77 (2014).</mixed-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>D</given-names></name><etal/></person-group><article-title>Culture media and individual hosts affect the recovery of culturable bacterial diversity from amphibian skin</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1574</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01574</pub-id><pub-id pub-id-type="pmid">28883811</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walke</surname><given-names>JB</given-names></name><name><surname>Harris</surname><given-names>RN</given-names></name><name><surname>Reinert</surname><given-names>LK</given-names></name><name><surname>Rollins-Smith</surname><given-names>LA</given-names></name><name><surname>Woodhams</surname><given-names>DC</given-names></name></person-group><article-title>Social immunity in amphibians: Evidence for vertical transmission of innate defenses</article-title><source>Biotropica</source><year>2011</year><volume>43</volume><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1111/j.1744-7429.2011.00787.x</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Bast, F. Sequence similarity search, multiple sequence alignment, model selection, distance matrix and phylogeny reconstruction. <italic>Protoc. Exch</italic>, 10.1038/protex.2013.065 (2013).</mixed-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title>Interactive Tree of Life v2: Online annotation and display of phylogenetic trees made easy</article-title><source>Nucleic Acids Res.</source><year>2011</year><volume>39</volume><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr201</pub-id><pub-id pub-id-type="pmid">20852262</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title>Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><fpage>127</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btl529</pub-id><pub-id pub-id-type="pmid">17050570</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Primer on agar-based microbial imaging mass spectrometry</article-title><source>J. Bacteriol.</source><year>2012</year><volume>194</volume><fpage>6023</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1128/JB.00823-12</pub-id><pub-id pub-id-type="pmid">22821974</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mass spectral similarity for untargeted metabolomics data analysis of complex mixtures</article-title><source>Int. J. Mass Spectrom.</source><year>2015</year><volume>377</volume><fpage>719</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.ijms.2014.06.005</pub-id><pub-id pub-id-type="pmid">25844058</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Indexing the Pseudomonas specialized metabolome enabled the discovery of poaeamide B and the bananamides</article-title><source>Nat. Microbiol.</source><year>2016</year><volume>2</volume><fpage>16197</fpage><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.197</pub-id><pub-id pub-id-type="pmid">27798598</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Wang, M. <italic>et al</italic>. Sharing and community curation of mass spectrometry data with GNPS. <italic>Nat. Biotechnol</italic>. (2016).</mixed-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nothias</surname><given-names>L-F</given-names></name><etal/></person-group><article-title>Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation</article-title><source>J. Nat. Prod.</source><year>2018</year><volume>81</volume><fpage>758</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00737</pub-id><pub-id pub-id-type="pmid">29498278</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boya</surname><given-names>CA</given-names></name><name><surname>Herrera</surname><given-names>L</given-names></name><name><surname>Guzman</surname><given-names>HM</given-names></name><name><surname>Gutierrez</surname><given-names>M</given-names></name></person-group><article-title>Antiplasmodial activity of bacilosarcin A isolated from the octocoral-associated bacterium <italic>Bacillus</italic> sp. collected in Panama</article-title><source>J. Pharm. Bioallied Sci.</source><year>2012</year><volume>4</volume><fpage>66</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4103/0975-7406.92739</pub-id><pub-id pub-id-type="pmid">22368402</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">CLSI. M38-A2 Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard - Second Edition. <italic>Clin. Lab. Stand. Inst</italic>. <bold>28</bold>, 29 (2008).</mixed-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arendrup</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Breakthrough <italic>Aspergillus fumigatus</italic> and <italic>Candida albicans</italic> double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing</article-title><source>Antimicrob. Agents Chemother.</source><year>2009</year><volume>53</volume><fpage>1185</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1128/AAC.01292-08</pub-id><pub-id pub-id-type="pmid">19104024</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins-Smith</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Antimicrobial peptide defenses against pathogens associated with global amphibian declines</article-title><source>Dev. Comp. Immunol.</source><year>2002</year><volume>26</volume><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/S0145-305X(01)00041-6</pub-id><pub-id pub-id-type="pmid">11687264</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rollins-Smith</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Activity of antimicrobial skin peptides from ranid frogs against <italic>Batrachochytrium dendrobatidis</italic>, the chytrid fungus associated with global amphibian declines</article-title><source>Dev. Comp. Immunol.</source><year>2002</year><volume>26</volume><fpage>471</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0145-305X(01)00088-X</pub-id><pub-id pub-id-type="pmid">11906726</pub-id></element-citation></ref></ref-list></back></article>